Saturday, October 3, 2026

Zoomex Wins US, Canada Crypto Licenses as Exchanges Race for Regulatory Access

Zoomex secured Money Services Business licenses in the United States and Canada, joining exchanges worldwide pursuing regulatory approval to access institutional capital. The dual licensing requires anti-money laundering controls and transaction monitoring aligned with traditional banking standards. The move reflects industry-wide recognition that compliance has become essential for institutional crypto adoption.

LM Salvado
LM Salvado

April 16, 2026

Zoomex Wins US, Canada Crypto Licenses as Exchanges Race for Regulatory Access
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Zoomex secured Money Services Business (MSB) licenses in the United States and Canada, joining exchanges worldwide pursuing regulatory approval to access institutional capital.1

The dual-jurisdiction licensing requires anti-money laundering controls, customer identification procedures, and transaction monitoring systems aligned with traditional banking standards.1 Zoomex also obtained licensing from Mantle, though operational details remain limited.1

The regulatory push extends beyond North America. European exchanges operate under MiCA regulations, while Asian platforms navigate fragmented frameworks from Singapore's Payment Services Act to Japan's strict licensing regime. The US-Canada MSB approach creates standardized oversight comparable to money transmitters and payment processors.

Traditional financial institutions are increasing crypto infrastructure investments. Regulatory clarity in major markets reduces operational risk for banks and asset managers considering crypto trading services. Asset managers require exchanges to meet specific regulatory thresholds before directing client capital to digital asset platforms.

MSB status addresses institutional concerns about counterparty risk and compliance liability. For retail investors globally, regulated exchange status provides consumer protections and oversight through financial reporting, capital requirements, and operational transparency that unlicensed platforms lack.

The compliance trend marks a strategic shift from crypto's historically libertarian stance on financial regulation. Exchanges now view regulatory costs and operational restrictions as acceptable trade-offs for institutional capital inflows.

Traditional finance integration with crypto platforms will likely accelerate through 2026 as more exchanges complete regulatory processes in key jurisdictions. The infrastructure gap between legacy banking systems and crypto markets continues to narrow as exchanges worldwide adopt conventional financial controls.

About this analysis

This is a Via News analysis. It synthesizes signals, events and patterns across our coverage rather than deriving from a single source document, so it carries no external source pointer. Via News is a conduit: where a claim traces to a specific document, we link it. How we source

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com